Nicorette Invisi 15mg Patch Step 2 Quit Smoking Aid 7 Patches

Key Product Selling Point

• Clinically proven to relieve and prevent nicotine cravings and withdrawal symptoms associated with quitting smoking or cutting down the number of cigarettes you smoke

• Transparent, discreet patch design blends invisibly with your skin, allowing you to wear it anywhere anytime without anyone knowing

• Fights 7 withdrawal symptoms—cravings, irritability, low mood, restlessness, anxiety, poor concentration and increased appetite—for comprehensive smoking cessation support

• Provides controlled nicotine absorption through the skin into the bloodstream for up to 16 hours of all-day craving control

• Specifically designed to be removed at night to help prevent sleep disturbances, supporting both your quit attempt and your rest

Detailed Product Description
This product, Nicorette Invisi 15mg Patch Step 2 in a pack of 7 patches, is used to relieve and/or prevent nicotine withdrawal symptoms and reduce the cravings you get when you try to stop smoking or when cutting down the number of cigarettes you smoke. Nicorette InvisiPatch is an effective once-a-day transdermal nicotine patch that helps you deal with nicotine cravings and withdrawal symptoms associated with giving up smoking. It provides a safer alternative to smoking for both the individual and those around them. The invisible, semi-transparent patch is specially designed to be discreet, so you can wear it without anyone noticing. Nicorette Invisipatch is specifically designed to be removed at night so as not to disturb your sleep, while still providing up to 16 hours of craving relief during your waking hours. This pack contains 7 patches and is recommended as Step 2 in the Nicorette step‑down programme, ideally for use after completion of Step 1 or for lighter smokers (those who smoke fewer than 15 cigarettes per day). Each patch is 13.5 cm², containing 1.75 mg/cm² of nicotine, releasing a nominal 15 mg of nicotine over 16 hours.

Direction for Use
First thing each morning, apply one fresh patch to clean, dry, hairless, intact skin of the arm, chest, thigh or hip. Do not apply to oily, broken, irritated or damaged skin. Apply to a new part of your body each day; after 2 to 3 days, you may apply to a previous spot if there is no sign of irritation. When applying the patch, run your finger around the edge to ensure it adheres properly. Before going to sleep, remove the patch and dispose of it safely by folding it in half with the sticky sides together and placing it back in the original sachet. Use as part of the Nicorette step‑down programme: For heavy smokers (15+ cigarettes/day): Step 1 (25mg) for 8 weeks → Step 2 (15mg) for 2 weeks → Step 3 (10mg) for 2 weeks. For light smokers (<15 cigarettes/day): Step 2 (15mg) for 8 weeks → Step 3 (10mg) for 4 weeks. For adults and children aged 12 years and over.

Ingredients/Materials
Each transdermal patch contains Nicotine 1.75 mg/cm² (15 mg per 16 hours). Other ingredients are: Triglycerides, medium‑chain; Basic butylated methacrylate copolymer; Polyethylenterephthalate film (PET); Acrylate matrix; Acrylic adhesive solution; Potassium hydroxide; Croscarmellose sodium; Aluminium acetylacetonate; Release liner: Polyethylenterephthalate (PET) film single side aluminised, both sides siliconised; Printing ink solution; Blending varnish; Printing ink beige; Printing ink brown.

Product Warnings
Do not use if you are allergic to nicotine or any of the other ingredients. Keep out of the sight and reach of children. Nicotine can be toxic in small children; if a child has used or swallowed a nicotine patch, contact a doctor or your nearest accident and emergency department immediately. Before starting to use the product, read the enclosed leaflet carefully. Talk to your doctor, pharmacist or nurse for advice before using this product if you are pregnant or breastfeeding, have a history of heart disease, irregular heartbeat, stroke, severe or moderate liver or kidney disease, uncontrolled high blood pressure, stomach or duodenal ulcers, diabetes, an overactive thyroid or a tumour of the adrenal gland, or are taking other medicines such as theophylline, clozapine or ropinirole. Do not smoke or use any other nicotine‑containing products while using the patch. When you first use the patch, it may cause mild itching, burning or tingling; this should go away within 24 hours. If you have a rash or your skin is swollen or red, remove the patch and consult your doctor. Side effects may include skin irritation at the application site (redness, itching, rash, swelling, burning, tingling, numbness, pain or hives), headache, dizziness, nausea, trouble sleeping, unusual dreams or palpitations. Site reactions are common in the first two weeks and resolve quickly following removal of the patch. If you experience difficulty breathing, chest pain, irregular heartbeat, severe skin rash or swelling of the face, lips or throat, remove the patch immediately and seek emergency medical attention. Nicorette Invisi Patches should not be administered to persons under 18 years of age without recommendation from a healthcare professional.

Warranty Period & Shelf Life
This product has a shelf life of 3 years from the date of manufacture. Do not store above 25°C. Store in a cool, dry place away from direct sunlight and moisture. Do not use the product after the expiry date marked on the pack. 

For the latest information about shelf life, batch number, storage condition, it is recommended to review the product and ingredient list printed on the packaging prior to usage or consumption.

Manufacturer Address
McNeil Products Ltd, 50-100 Holmers Farm Way, High Wycombe, HP12 4EG, United Kingdom.

Net Content
7 transdermal patches (each 13.5 cm², containing 15 mg of nicotine per 16 hours)